Skip to main
GOCO
GOCO logo

GoHealth, Inc. (GOCO) Stock Forecast & Price Target

GoHealth, Inc. (GOCO) Analyst Ratings

Based on 1 analyst ratings
Hold
Strong Buy 0%
Buy 0%
Hold 100%
Sell 0%
Strong Sell 0%

Bulls say

GoHealth Inc. reported a significant year-over-year revenue growth of 19.1% in Q1 2025, achieving $221.0 million, which surpassed both internal estimates and consensus forecasts. The company experienced a robust increase in total submissions, growing by 40.2% year-over-year to 303,000, primarily driven by a notable 64% growth in captive Medicare submissions, while agent headcount only increased by 24%. Additionally, membership persistency and lifetime value (LTV) have stabilized over the past two years, indicating a positive trend in the company's customer retention and overall market strategy amidst industry adjustments.

Bears say

GoHealth Inc. is experiencing a decline in revenue per sale, which fell by 15.4% to $724, primarily attributed to a shift in submission types from non-agency to agency. Despite a substantial year-over-year improvement in adjusted EBITDA, with a reported figure of $42.1 million in Q1 2025, the company faces potential headwinds in persistency that could negatively impact future revenue and cash received from commissions. The downside scenario analysis indicates a possibility of adjusted EBITDA being approximately 25% lower than base case estimates, suggesting a decreased valuation multiple of the company's earnings.

GoHealth, Inc. (GOCO) has been analyzed by 1 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 0% recommend Buy, 100% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GoHealth, Inc. and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GoHealth, Inc. (GOCO) Forecast

Analysts have given GoHealth, Inc. (GOCO) a Hold based on their latest research and market trends.

According to 1 analysts, GoHealth, Inc. (GOCO) has a Hold consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GoHealth, Inc. (GOCO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.